UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023243
Receipt number R000026431
Scientific Title Comparison of the efficacy of sitagliptin 25mg and teneligliptin 20mg in patient with type2 diabetes and chronic kidney disease.
Date of disclosure of the study information 2016/07/20
Last modified on 2025/03/06 19:25:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of the efficacy of sitagliptin 25mg and teneligliptin 20mg in patient with type2 diabetes and chronic kidney disease.

Acronym

Comparison of the efficacy of sitagliptin 25mg and teneligliptin 20mg in patient with type2 diabetes and chronic kidney disease.

Scientific Title

Comparison of the efficacy of sitagliptin 25mg and teneligliptin 20mg in patient with type2 diabetes and chronic kidney disease.

Scientific Title:Acronym

Comparison of the efficacy of sitagliptin 25mg and teneligliptin 20mg in patient with type2 diabetes and chronic kidney disease.

Region

Japan


Condition

Condition

type2 diabetes meliitus

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Comparison of the efficacy of sitagliptin 25mg and teneligliptin 20mg in patients with CKD and type 2 diabetes

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in blood glucose and HbA1c

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Distribution to a group as administration of sitagliptin 25mg for three months, followed by administration of teneligliptin 20mg for three months

Interventions/Control_2

Distribution to a group as administration of teneligliptin 20mg for three months, followed by administration of sitagliptin 25mg for three months

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

adult type 2 diabetes patients
Patients with renal function of eGFR 30~50ml/min/1.73m2, in oral teneligliptin 20mg
non insulin dependent state patients
patient's HbA1c are from 6 to 8 percent

Key exclusion criteria

Patients of both drugs is contraindicated
Pregnancy, patients in nursing
Patients suffering from a severe disease requiring hospitalization
Patients with anemia (Hb <10g / dl)
Patients undergoing steroid therapy
Patients attending physician was found to be inappropriate for any reason

Target sample size

30


Research contact person

Name of lead principal investigator

1st name YASUO
Middle name
Last name ZENIMARU

Organization

University of Fukui Hospital

Division name

Department of Endocrinology and Metabolism

Zip code

910-1193

Address

23-3 Shimoaitsuki Matsuoka Eiheiji-cho Yoshida-gun Fukui Japan

TEL

0776-61-3111

Email

zenimaru@u-fukui.ac.jp


Public contact

Name of contact person

1st name YASUO
Middle name
Last name ZENIMARU

Organization

University of Fukui Hospital

Division name

Department of Endocrinology and Metabolism

Zip code

910-1193

Address

23-3 Shimoaitsuki Matsuoka Eiheiji-cho Yoshida-gun Fukui Japan

TEL

0776-61-3111

Homepage URL


Email

zenimaru@u-fukui.ac.jp


Sponsor or person

Institute

Department of Endocrinology and Metabolism University of Fukui Hospital

Institute

Department

Personal name



Funding Source

Organization

N/A

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Certified Review Board, University of Fukui

Address

23-3 Shimoaitsuki Matsuoka Eiheiji-cho Yoshida-gun Fukui Japan

Tel

0776-61-8758

Email

tokutei@ml.u-fukui.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 07 Month 20 Day


Related information

URL releasing protocol

n.a.

Publication of results

Published


Result

URL related to results and publications

n.a.

Number of participants that the trial has enrolled

22

Results

The hypoglycemic effect obtained with 25 mg of sitagliptin was non-inferior to that of 20 mg of teneligliptin

Results date posted

2025 Year 03 Month 06 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Participants were randomly assigned to two groups for the crossover study: the S group, which was first treated with T for 3 months and then switched to sitagliptin 25 mg (S) for 3 months, and the T group, which was treated with S for 3 months and then treated with T for 3 months.

Participant flow

Twelve patients were assigned to the sitagliptin group and 10 to the teneligliptin group, and all completed the study.

Adverse events

none in particular

Outcome measures

HbA1c

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 04 Month 25 Day

Date of IRB

2016 Year 04 Month 25 Day

Anticipated trial start date

2016 Year 05 Month 02 Day

Last follow-up date

2018 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 07 Month 20 Day

Last modified on

2025 Year 03 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026431